Kytopen
Biotechnology Research • 
Cambridge, Massachusetts, United States • 21-50 Employees
Company overview
| Headquarters | 750 Main St, Cambridge, Massachusetts 02139, US |
| Phone number | +16173623058 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Gene Therapy, Manufacturing, Drug Discovery, Immunotherapy, Cell Therapy, Mechanical Engineering, Immunology, Stem Cells, Transfection, Crispr, Genetic Engineering, Gene Editing, Nk Cells, T Cells, Mrna, Mammalian Cells, Cas9, Cell Engineering, Car T-Cell, Cd34+ Stem Cells, Nonviral, Rnp Delivery |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Key Contacts at Kytopen
Daniel Weinstein
Business Development, Senior Director
Brian Kierce
Senior Director, Sales
Michael Chiu
Chief Executive Officer
Christopher Abraham
Director Application Development
Rameech Mccormack
Director Of Technology And Product Development
Leif Anderson
Associate Director, Field Applications
Maria Lai
Associate Director, Applications And Data
Conor Mccarron
Director Of Operations
John Zhao
Director Process Development
Laure Deflubé-Owen
Associate Director Research Development
Kytopen Email Formats
Kytopen uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@kytopen.com), used 56% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@kytopen.com | 56% |
{first name}{last name} | johndoe@kytopen.com | 36% |
{second initial}{last name} | odoe@kytopen.com | 4% |
{last name}{last name} | doedoe@kytopen.com | 4% |
About Kytopen
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect® platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect Discover™, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect Discover™ with the Flowfect Tx™ large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.
Kytopen revenue & valuation
| Annual revenue | $15,000,000 |
| Revenue per employee | $406,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $48,000,000 |
| Total funding | $31,780,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Kytopen has 12 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Kytopen's funding history, including investment rounds, total capital raised, and key backers.
Kytopen Tech Stack
Discover the technologies and tools that power Kytopen's digital infrastructure, from frameworks to analytics platforms.
Security
Security
CMS
JavaScript libraries
JavaScript libraries
Maps
CDN
Advertising
JavaScript libraries
Analytics
Webmail
Brazil
Canada
France
JapanFrequently asked questions
4.8
40,000 users
